Immunome, Inc.
News
TD Asset Management Inc Has $3.94 Million Stock Holdings in Immunome, Inc. (NASDAQ:IMNM)
Ticker Report TD Asset Management Inc increased its holdings in shares of Immunome, Inc. (NASDAQ:IMNM - Free Report) by 13.8% in the 2nd quarter, Holdings Channel.com reports. The firm owned 325,206 shares of the...\n more…
Immunome to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
Business Wire Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Clay Siegall, PhD, President and CEO of...\n more…
Immunome, Inc. (NASDAQ:IMNM) Shares Purchased by Wealth Enhancement Advisory Services LLC
Ticker Report Wealth Enhancement Advisory Services LLC increased its position in Immunome, Inc. (NASDAQ:IMNM - Free Report) by 279.5% in the second quarter, according to its most recent disclosure with the SEC...\n more…
Insider Selling: Immunome, Inc. (NASDAQ:IMNM) Insider Sells 3,524 Shares of Stock
Ticker Report Immunome, Inc. (NASDAQ:IMNM - Get Free Report) insider Jack Higgins sold 3,524 shares of the stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $13.93, for a...\n more…
Immunome, Inc. (NASDAQ:IMNM) Director Jean Jacques Bienaime Purchases 7,000 Shares
Ticker Report Immunome, Inc. (NASDAQ:IMNM - Get Free Report) Director Jean Jacques Bienaime purchased 7,000 shares of the stock in a transaction on Friday, August 16th. The shares were purchased at an average cost...\n more…